GSK329 is a potent and selective diarylurea inhibitor of the cardiac-specific kinase TNNI3K. GSK329 exhibits positive cardioprotective outcomes in the model of ischemia/reperfusion cardiac injury[1].
Molecular Weight:
472.25
Purity:
99.60
CAS Number:
[1268490-12-5]
Formula:
C19H14Cl2F3N5O2
Target:
MAP3K
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted